Charles Deignan - Sep 18, 2023 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CLSD	Employee Stock Option (right to buy)	Award	$0	+100K		$0.00	100K	Sep 18, 2023	Common Stock	100K	$0.85	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	One-third of the shares underlying this option vest on September 18, 2024 and the balance of the shares vest in a series of 24 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such vesting date.